NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 6 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $320,815 | +71.3% | 352,660 | +7.0% | 0.06% | +75.8% |
| Q2 2023 | $187,247 | +5.4% | 329,660 | +16.0% | 0.03% | 0.0% |
| Q1 2023 | $177,600 | -20.7% | 284,160 | -0.5% | 0.03% | -32.7% |
| Q4 2022 | $223,943 | +9.8% | 285,460 | +0.1% | 0.05% | 0.0% |
| Q3 2022 | $204,000 | +14.0% | 285,160 | +0.2% | 0.05% | +16.7% |
| Q2 2022 | $179,000 | -7.7% | 284,460 | +2.2% | 0.04% | +10.5% |
| Q1 2022 | $194,000 | +19.8% | 278,465 | +20.0% | 0.04% | +35.7% |
| Q4 2021 | $162,000 | -24.7% | 232,065 | +37.9% | 0.03% | -28.2% |
| Q3 2021 | $215,000 | -8.5% | 168,265 | +5.4% | 0.04% | -9.3% |
| Q2 2021 | $235,000 | +13.5% | 159,665 | +14.9% | 0.04% | +4.9% |
| Q1 2021 | $207,000 | +30.2% | 138,945 | +33.5% | 0.04% | +17.1% |
| Q4 2020 | $159,000 | +318.4% | 104,050 | +110.6% | 0.04% | +250.0% |
| Q3 2020 | $38,000 | +245.5% | 49,400 | +54.4% | 0.01% | +233.3% |
| Q2 2020 | $11,000 | +120.0% | 32,000 | +3.2% | 0.00% | +50.0% |
| Q1 2020 | $5,000 | – | 31,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 24,815,028 | $8,638,000 | 0.42% |
| HYMAN CHARLES D | 249,625 | $87,000 | 0.01% |
| Montecito Bank & Trust | 75,717 | $26,000 | 0.01% |
| WEDBUSH SECURITIES INC | 127,200 | $44,000 | 0.01% |
| BIEGEL & WALLER LLC | 11,500 | $5,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 31,660 | $11,000 | 0.00% |
| MAIRS & POWER INC | 12,500 | $4,000 | 0.00% |
| BRANDES INVESTMENT PARTNERS, LP | 65,000 | $23,000 | 0.00% |